Invasive fungal infections after CD19 chimeric antigen receptor T-cell therapy for B-cell lymphoma: a Lymphoma study association study from the DESCAR-T (Dispositif d’Enregistrement et Suivi des patients traités par CAR-T cells) registry

20251 citationsJournal Articlehybrid Open Access

Authors

Amélie Bouvier · Université Paris-Est Créteil

Amandine Durand · Maison des Sciences sociales et des Humanités de Dijon

Vivien Dupont · The Lymphoma Academic Research Organisation

Nicolas Gower · Université de Lille

C. Lorente · Institut Gustave Roussy

Arnaud Campidelli · Centre Hospitalier Régional et Universitaire de Nancy

Rémi Dulery

Abstract

Despite the low incidence of IFI in B-cell lymphoma patients treated with CD19 CAR T-cell therapy, the high infectious mortality underscore the need for individualized prophylaxis and rapid diagnosis for high-risk patients.

Topics & Keywords

CAR-T cell therapy research

Publication Details

Published in: Clinical Microbiology and Infection

Volume 32, Issue 2, pp. 277-284

DOI: 10.1016/j.cmi.2025.10.005

Field-Weighted Citation Impact: 1.10

Command Palette

Invasive fungal infections after CD19 chimeric antigen receptor T-cell therapy for B-cell lymphoma: a Lymphoma study association study from the DESCAR-T (Dispositif d’Enregistrement et Suivi des patients traités par CAR-T cells) registry

Authors

Abstract

Topics & Keywords

Publication Details